A detailed history of American International Group, Inc. transactions in Pulmonx Corp stock. As of the latest transaction made, American International Group, Inc. holds 18,355 shares of LUNG stock, worth $116,370. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,355
Previous 18,233 0.67%
Holding current value
$116,370
Previous $232,000 26.72%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$8.71 - $14.65 $1,062 - $1,787
122 Added 0.67%
18,355 $170,000
Q4 2023

Feb 13, 2024

SELL
$7.89 - $13.14 $583 - $972
-74 Reduced 0.4%
18,233 $232,000
Q3 2023

Nov 13, 2023

BUY
$9.88 - $14.0 $6,441 - $9,128
652 Added 3.69%
18,307 $189,000
Q2 2023

Aug 04, 2023

BUY
$10.78 - $13.65 $12,375 - $15,670
1,148 Added 6.95%
17,655 $231,000
Q1 2023

May 12, 2023

BUY
$7.49 - $12.54 $2,464 - $4,125
329 Added 2.03%
16,507 $184,000
Q4 2022

Feb 10, 2023

SELL
$4.92 - $17.35 $290 - $1,023
-59 Reduced 0.36%
16,178 $136,000
Q3 2022

Nov 14, 2022

BUY
$15.35 - $23.99 $3,530 - $5,517
230 Added 1.44%
16,237 $271,000
Q2 2022

Aug 12, 2022

BUY
$14.0 - $27.95 $42,616 - $85,079
3,044 Added 23.48%
16,007 $236,000
Q1 2022

May 13, 2022

SELL
$21.13 - $35.65 $19,270 - $32,512
-912 Reduced 6.57%
12,963 $322,000
Q4 2021

Feb 11, 2022

SELL
$29.72 - $45.1 $12,333 - $18,716
-415 Reduced 2.9%
13,875 $445,000
Q3 2021

Nov 12, 2021

BUY
$35.98 - $44.48 $2,122 - $2,624
59 Added 0.41%
14,290 $514,000
Q2 2021

Aug 13, 2021

BUY
$37.61 - $48.0 $280,721 - $358,272
7,464 Added 110.3%
14,231 $628,000
Q1 2021

May 07, 2021

BUY
$44.0 - $67.54 $792 - $1,215
18 Added 0.27%
6,767 $310,000
Q4 2020

Feb 12, 2021

BUY
$39.31 - $69.02 $265,303 - $465,815
6,749 New
6,749 $466,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.